Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-019621

Chief Financial Officer sold 10,000 shares at an average $40.24 ($402,425)

  • Chief Financial Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Cohen Chad M · Chief Financial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-03-09 Exercise or conversion : show line 1 in the form +10,000 $6.32 $63,200 31,064 D
2021-03-09 Sale : show line 2 in the form −7,110 $40.02 $284,542 23,954 D
2021-03-09 Sale : show line 3 in the form −2,890 $40.79 $117,883 21,064 D
Open-market sales · 10,000 sh · avg $40.24 · $402,425

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-03-09 Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) −10,000 55,000 D
Loading xslF345X03/doc4.xml…